(Q54710399)

3 June 2018

title

VEGFR2 is selectively expressed by FOXP3high CD4+ Treg. (English)

1 reference

3 June 2018

author name string

Hiroyuki Suzuki

1

1 reference

3 June 2018

Hideya Onishi

2

1 reference

3 June 2018

Junji Wada

3

1 reference

3 June 2018

Akio Yamasaki

4

1 reference

3 June 2018

Haruo Tanaka

5

1 reference

3 June 2018

Kenji Nakano

6

1 reference

3 June 2018

Takashi Morisaki

7

1 reference

3 June 2018

Mitsuo Katano

8

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 January 2010

1 reference

3 June 2018

European Journal of Immunology

published in

1 reference

3 June 2018

volume

40

1 reference

3 June 2018

page(s)

197-203

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

FOXP3: of mice and men.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Regulating the immune system: the induction of regulatory T cells in the periphery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Regulatory T cells: development, function and role in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

VEGF-receptor signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Cancer without disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939887

7 January 2021

Identifiers

DOI

10.1002/EJI.200939887

1 reference

3 June 2018

PubMed ID

19902430

1 reference

3 June 2018